Systemic Lupus Erythematosus

  • Jerry C. Jacobs
Part of the Comprehensive Manuals in Pediatrics book series (CM PEDIATRICS)

Abstract

It was 1954. A 13-year-old girl became ill with fever, arthritis, a butterfly facial rash, diplopia, alopecia, and subcutaneous nodules (Fig. 5.1). Her urinalysis showed some protein and 20 red blood cells. A diagnosis of systemic lupus erythematosus (SLE) was made, and treatment was begun with 50 mg of prednisone daily. There was a dramatic response, and she began to feel well. Her chart was filled with notes of concern about the potential fearsome side effects of prednisone and its merely palliative benefits. As soon as she felt a little better, her doctors would reduce the prednisone; she would promptly become ill again. During the 21 months she survived, she was continuously ill and was hospitalized 10 times for a total 220 hospital days before she died of renal failure.

Keywords

Lupus Nephritis Mixed Connective Tissue Disease Renal Vein Thrombosis Discoid Lupus Erythematosus Systemic Lupus Erythe 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Good RA, Venters H, Page AR, et al.: Diffuse connective tissue diseases in childhood. Lancet 81: 192–204, 1961.Google Scholar
  2. 2.
    Decker JL, Steinberg AD, Reinertsen JL, et al.: Systemic lupus erythematosus: Evolving concepts. Ann Intern Med 91: 587–604, 1979.PubMedGoogle Scholar
  3. 3.
    Koffler D: Systemic lupus erythematosus. Scientific American, July 1980, pp. 5261Google Scholar
  4. 4.
    Jacobs JC: Systemic lupus erythematosus in childhood. Pediatrics 32: 257–264, 1963.PubMedGoogle Scholar
  5. 5.
    Meislin AG, Rothfield N: Systemic lupus erythematosus in childhood. Pediatrics 42: 37–49, 1968.PubMedGoogle Scholar
  6. 6.
    Waldavens PA, Chase P: The prognosis of childhood systemic lupus erythematosus. Am J Dis Child 130: 929–933, 1976.Google Scholar
  7. 7.
    King KK, Kornreich HK, Bernstein BH, et al.: The clinical spectrum of systemic lupus erythematosus in childhood. Arthritis Rheum 20: 287–294, 1977.PubMedGoogle Scholar
  8. 8.
    Norris DG, Colon AR, Stickler GB: Systemic lupus erythematosus in children. Clin Pediatr 16: 774–778, 1977.Google Scholar
  9. 9.
    Cassidy JT, Sullivan DB, Petty RE, et al.: Lupus nephritis and encephalopathy: Prognosis in 58 children. Arthritis Rheum 20: 315–322, 1977.PubMedGoogle Scholar
  10. 10.
    Fish AJ, Blau EB, Westberg NG, et al.: Systemic lupus erythematosus within the first two decades of life. Am J Med 62: 99–117, 1977.PubMedGoogle Scholar
  11. 11.
    Masi AT, Kaslow RA: Sex effects in systemic lupus erythematosus. Arthritis Rheum 21: 480–484, 1978.PubMedGoogle Scholar
  12. 12.
    Siegel M, Lee SL: The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 3: 1–54, 1973.PubMedGoogle Scholar
  13. 13.
    Kaslow RA, Masi AT: Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum 21: 473–484, 1978.PubMedGoogle Scholar
  14. 14.
    Dubois EL: Lupus Erythematosus, 2nd ed. University of California Press, Los Angeles, 1974.Google Scholar
  15. 15.
    Block SR, Winfield JB, Lockshin MD, et al.: Studies of twins with systemic lupus erythematosus. Am J Med 59: 533–552, 1975.PubMedGoogle Scholar
  16. 16.
    Arnett FC, Shulman LE: Studies in familial systemic lupus erythematosus. Medicine 55: 313–322, 1976.PubMedGoogle Scholar
  17. 17.
    Scherak O, Smolen JS, Mayr WR: HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum 23: 954–957, 1980.PubMedGoogle Scholar
  18. 18.
    Cleland LG: Familial lupus: Family studies of HLA and serologic findings. Arthritis Rheum 21: 183–191, 1978.PubMedGoogle Scholar
  19. 19.
    Morris RJ, Freed CR, Kohler PF: Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus. Arthritis Rheum 22: 777–780, 1979.PubMedGoogle Scholar
  20. 20.
    Reidenberg MM, Levy M, Drayer DE, et al.: Acetylator phenotype in idiopathic systemic lupus erythematosus. Arthritis Rheum 23: 569–573, 1980.PubMedGoogle Scholar
  21. 21.
    Ortiz Neu C, LeRoy EC: The coincidence of Klinefelter’s syndrome and systemic lupus erythematosus. Arthritis Rheum 12: 241–246, 1969.PubMedGoogle Scholar
  22. 22.
    Cram DL, Epstein JH, Tuffanelli DL: Lupus erythematosus and porphyria. Arch Dermatol 108: 779–784, 1973.PubMedGoogle Scholar
  23. 23.
    Sakane T, Steinberg AD, Green I: Studies of immune functions of patients with systemic lupus erythematosus. Arthritis Rheum 23: 225–231, 1980.PubMedGoogle Scholar
  24. 24.
    Ruiz-Arguelles A, Alarcon-Segovia D, Llorente L, et al.: Heterogeneity of the spontaneously expanded and mitogen-induced generation of suppressor cell function of T cells on B cells in systemic lupus erythematosus. Arthritis Rheum 23: 1004–1009, 1980.PubMedGoogle Scholar
  25. 25.
    Unanue ER: Cooperation between mononuclear phagocytes and lymphocytes in immunity. N Engl J Med 303: 977–985, 1980.PubMedGoogle Scholar
  26. 26.
    Frank MM, Hamburger MI, Lawley TJ, et al.: Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518523, 1979.Google Scholar
  27. 27.
    Inman RD: Immunologic sex differences and the female preponderance in systemic lupus erythematosus. Arthritis Rheum 21: 849–852, 1978.PubMedGoogle Scholar
  28. 28.
    DeHoratius RJ, Messner RP: Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus. J Clin Invest 55: 1254–1258, 1975.PubMedGoogle Scholar
  29. 29.
    Folomeeva O, Nassonova VA, Alekberova AS: Comparative studies of antilymphocyte, antipolynucleotide, and antiviral antibodies among families of patients with systemic lupus erythematosus. Arthritis Rheum 21: 23–27, 1978.PubMedGoogle Scholar
  30. 30.
    Miller KB, Schwartz RA: Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med 301: 803–809, 1979.PubMedGoogle Scholar
  31. 31.
    Messner RP, DeHoratius R, Ferrone S: Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives. Arthritis Rheum 23: 265–270, 1980.PubMedGoogle Scholar
  32. 32.
    Seibold JR, Lynch CJ: Disco lupus, a new disease syndrome (letter). Arthritis Rheum 23: 962–963, 1980.PubMedGoogle Scholar
  33. 33.
    Tan EM: Sunlight as a potential etiological factor in systemic lupus erythematosus. In: Hughes GRV (ed.) Modern Topics in Rheumatology. Heinemann, London, 1976, pp. 99–106.Google Scholar
  34. 34.
    Agnello V: Complement deficiency states. Medicine 57: 1–23, 1978.PubMedGoogle Scholar
  35. 35.
    Zeitz HJ, Miller GW, Lint TF, et al.: Deficiency of C7 with systemic lupus erythematosus. Arthritis Rheum 24: 87–93, 1981.PubMedGoogle Scholar
  36. 36.
    Colten HR, Alper CA, Rosen FS: Genetics and biosynthesis of complement proteins. N Engl J Med 304: 653–656, 1981.PubMedGoogle Scholar
  37. 37.
    Wilson CB, Dixon FJ: Immunologic mechanisms in nephritogenesis. Hosp Pract 14: 57–69, 1979.PubMedGoogle Scholar
  38. 38.
    Couser WG: What are circulating immune complexes doing in glomerulonephritis? N Engl J Med 304: 1230–1232, 1981.PubMedGoogle Scholar
  39. 39.
    Waller SJ, Taylor RP, Wright EL, et al.: DNA/anti-DNA complexes. Arthritis Rheum 24: 651–657, 1981.PubMedGoogle Scholar
  40. 40.
    Panem S, Ordonez NG, Kirstein WH, et al.: C-type virus expression in systemic lupus erythematosus. N Engl J Med 295: 470–475, 1976.PubMedGoogle Scholar
  41. 41.
    Phillips PE: Viruses and systemic lupus erythematosus. Bull Rheum Dis 28: 954958, 1978.Google Scholar
  42. 42.
    Abrass CK, Nies KM, Louie JS, et al.: Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 23: 273–282, 1980.PubMedGoogle Scholar
  43. 43.
    Lange K, Ores R, Strauss W, et al.: Steroid therapy of systemic lupus erythematosus based on immunologic considerations. Arthritis Rheum 8: 244–259, 1965.PubMedGoogle Scholar
  44. 44.
    Gewurz H, et al.: The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol 34: 556–570, 1968.PubMedGoogle Scholar
  45. 45.
    Kohler PF, Ten Besel R: Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus. Clin Exp Immunol 4: 191–202, 1969.PubMedGoogle Scholar
  46. 46.
    Ruddy S, Carpenter CB, Chin KW, et al.: Human complement metabolism: An analysis of 144 studies. Medicine 54: 165–178, 1975.Google Scholar
  47. 47.
    Deicher HRG, Homan HR, Kunkel HG: The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J Exper Med 109: 97–114, 1959.Google Scholar
  48. 48.
    Schur PH, Carr RI, Kunkel HG: Desoxyribonuclease acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45: 1732–1740, 1966.PubMedGoogle Scholar
  49. 49.
    Pincus T, Schur PH, Rose JA, et al.: Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engi J Med 281: 701–705, 1969.Google Scholar
  50. 50.
    Hughes GRV: Significance of anti-DNA antibodies in systemic lupus erythematosus. Lancet 2: 861–863, 1971.PubMedGoogle Scholar
  51. 51.
    Pincus T, Hughes GRV, Pincus D, et al.: Antibodies to DNA in childhood systemic lupus erythematosus. J Pediatr 78: 981–984, 1971.PubMedGoogle Scholar
  52. 52.
    Koffler D, Agnello V, Winchester R, et al.: The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest 52: 198–204, 1973.PubMedGoogle Scholar
  53. 53.
    Lightfoot RW, Hughes GRV: Significance of persisting serologic abnormalities in systemic lupus erythematosus. Arthritis Rheum 19: 837–843, 1976.PubMedGoogle Scholar
  54. 54.
    Appel AE, Sablay LB, Golden RA, et al.: The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis. Am J Med 64: 274–283, 1978.PubMedGoogle Scholar
  55. 55.
    Adler MK, Baumgarten A, Hecht B, et al.: Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis. Ann Rheum Dis 34: 444–450, 1975.PubMedGoogle Scholar
  56. 56.
    Wold RT, Young FE, Tan EM, et al.: Desoxyribonucleic acid antibody: A method to detect its primary interaction with desoxyribonucleic acid. Science 161: 806–807, 1968.PubMedGoogle Scholar
  57. 57.
    Winfield JB, Brunner CM, Koffler D: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 21: 289–294, 1978.PubMedGoogle Scholar
  58. 58.
    Yang LC, Norman ME, Doughty RA: A micromethod for the analysis of cryoglobulins via laser nephelometry: Evaluation in comparison to Ciq binding activity in autoimmune diseases in pediatrics. Pediatr Res 14: 858–862, 1980.PubMedGoogle Scholar
  59. 59.
    Cohen AS, Reynolds WE, Franklin EC, et al.: Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21: 643–648, 1971.Google Scholar
  60. 60.
    Lehman TA, Hanson V, Singsen B, et al.: Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus. Arthritis Rheum 22: 954–958, 1979.PubMedGoogle Scholar
  61. 61.
    Gladman DD, Chalmers A, Urowitz MB: Systemic lupus erythematosus with negative lupus erythematosus cells and antinuclear factor. J Rheum 4: 142–147, 1978.Google Scholar
  62. 62.
    Tan EM: Systemic lupus erythematosus—immunologic aspects. In: McCarty DJ (ed.) Arthritis and Allied Conditions, 9th ed. Lea and Febiger, Philadelphia, 1979, pp. 715–722.Google Scholar
  63. 63.
    Harrist TJ, Mihm MC Jr.: The specificity and clinical usefulness of the lupus band test. Arthritis Rheum 23: 479–490, 1980.PubMedGoogle Scholar
  64. 64.
    Appel GB, Silva FG, Pirani CL, et al.: Renal involvement in systemic lupus erythematosus. Medicine 57: 371–410, 1978.PubMedGoogle Scholar
  65. 65.
    Libit SA, Burke M, Michael A, et al.: Extramembranous glomerulonephritis in childhood: Relationship to systemic lupus erythematosus. J Pediatr 88: 394–402, 1976.PubMedGoogle Scholar
  66. 66.
    Morris RJ, Guggenheim SJ, McIntosh RM, et al.: Simultaneous immunologic studies of skin and kidney in systemic lupus erythematosus. Arthritis Rheum 22: 864–870, 1979.PubMedGoogle Scholar
  67. 67.
    Mahajan SK, Ordonez NG, Feitelson PJ, et al.: Lupus nephropathy without clinical renal involvement. Medicine 56: 493–501, 1977.PubMedGoogle Scholar
  68. 68.
    Woolf A, Croker B, Osofsky SG, et al.: Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment. Pediatrics 64: 678–685, 1979.PubMedGoogle Scholar
  69. 69.
    Baldwin DS, Gluck MC, Lowenstein J, et al.: Lupus nephritis. Clinical course as related to morphologic forms and their transition. Am J Med 62: 12–30, 1977.PubMedGoogle Scholar
  70. 70.
    McCluskey RT: Lupus nephritis. In: Sommers SC (ed.) Kidney Pathology Decennial 1966–1975. Appleton-Century-Crofts, New York, 1975, pp. 435–460.Google Scholar
  71. 71.
    Barnett HL: International study of kidney disease in children. Personal communication.Google Scholar
  72. 72.
    Ginzler EM, Bollet AJ, Friedman EA: The natural history and response to therapy of lupus nephritis. Ann Rev Med 31: 463–487, 1980.PubMedGoogle Scholar
  73. 73.
    Appel GB, Williams GS, Meltzer JI, et al.: Renal vein thrombosis, nephrotic syndrome, and systemic lupus erythematosus: An association in four cases. Ann Intern Med 85: 310–317, 1976.PubMedGoogle Scholar
  74. 74.
    Donadio JV, Burgess JH, Holley KE: Membranous lupus nephropathy: A clinicopathologic study. Medicine 56: 527–536, 1977.PubMedGoogle Scholar
  75. 75.
    Ross DI, Lubowitz R: Anticoagulation in renal vein thrombosis. Arch Intern Med 138: 1349–1351, 1978.PubMedGoogle Scholar
  76. 76.
    Mailloux LU, Susin M, Stein HL, et al.: Nephrotic syndrome, membranous nephropathy, and renal vein thrombosis: Long-term follow-up. NY State J Med 78: 1873–1879, 1978.Google Scholar
  77. 77.
    Fries JF, Holman HR: Systemic Lupus Erythematosus: A Clinical Analysis. Saunders, Philadelphia, 1975.Google Scholar
  78. 78.
    Fries JF, Weyl S, Holman HR: Estimating prognosis in systemic lupus erythematosus. Am J Med 57: 561–565, 1974.PubMedGoogle Scholar
  79. 79.
    Jacobs JC: Childhood onset systemic lupus erythematosus. NY State J Med 77: 2231–2233, 1977.Google Scholar
  80. 80.
    Urowitz MB, Bookman AAM, Koehler BE, et al.: The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60: 221–225, 1976.PubMedGoogle Scholar
  81. 81.
    Estes D, Christian CL: The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50: 85–95, 1971.PubMedGoogle Scholar
  82. 82.
    Karsh J, Klippel JH, Barlow JE, et al.: Mortality in lupus nephritis. Arthritis Rheum 22: 764–769, 1979.PubMedGoogle Scholar
  83. 83.
    Rosner S, Ginzler E, Diamond H, et al.: Causes of death in systemic lupus erythematosus, abstracted. Arthritis Rheum 23: 738, 1980.Google Scholar
  84. 84.
    Spiera H, Swerdlow F, Johnson S, et al.: Myocardial infarction in young patients with chronic systemic lupus erythematosus. Abstracted. Arthritis Rheum 24 [Suppl.]: 120, 1981.Google Scholar
  85. 85.
    Jacobs JC: Lupus erythematosus with nephritis. Pediatrics 41: 369–370, 1968.Google Scholar
  86. 86.
    Ropes MW: Systemic Lupus Erythematosus. Harvard University Press, Cambridge, Mass., 1976.Google Scholar
  87. 87.
    Canuso JJ, Cohen AS: A review of the use, evaluations, and criticisms of the preliminary criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 22: 917–921, 1979.Google Scholar
  88. 88.
    Ragsdale CG, Petty RE, Cassidy JT, et al.: The clinical progression of apparent juvenile rheumatoid arthritis to systemic lupus erythematosus. J Rheum 7: 50–55, 1980.PubMedGoogle Scholar
  89. 89.
    Manthorpe R, Bendixen G, Schiller H, et al.: Jaccoud’s syndrome. A nosographic entity associated with systemic lupus erythematosus. J Rheum 7: 169–177, 1980.PubMedGoogle Scholar
  90. 90.
    Zizic TM, Shulman LE, Stevens MB: Colonic perforations in systemic lupus erythematosus. Medicine 54: 411–426, 1975.PubMedGoogle Scholar
  91. 91.
    Case records of the Massachusetts General Hospital (case no. 25–1978). New Engl J Med 298: 1463–1470, 1978.Google Scholar
  92. 92.
    Goldberg BH, Bergstein JM: Acute respiratory distress in a child after steroid-induced pancreatitis. Pediatrics 61: 317–318, 1978.PubMedGoogle Scholar
  93. 93.
    Alverson DC, Chase HP: Systemic lupus erythematosus in childhood presenting as hyperlipoproteinemia. J Pediatr 91: 72–75, 1977.PubMedGoogle Scholar
  94. 94.
    Lipsky PE, Hardin JA, Schour L, et al.: Spontaneous peritonitis and systemic lupus erythematosus. JAMA 232: 929–931, 1975.Google Scholar
  95. 95.
    Lloyd DD, Balfe JW, Barkin M, et al.: Systemic lupus erythematosus with signs of retroperitoneal fibrosis. J Pediatr 85: 226–228, 1974.Google Scholar
  96. 96.
    Bitran J, McShane D, Ellman MH: Ascites as the major manifestation of systemic lupus erythematosus. Arthritis Rheum 19: 782–785, 1976.PubMedGoogle Scholar
  97. 97.
    Tsukahara M, Matsuo K, Kojima H: Protein-losing enteropathy in a boy with systemic lupus erythematosus. J Pediatr 97: 778–780, 1980.PubMedGoogle Scholar
  98. 98.
    Case Records of the Massachusetts General Hospital (case no. 42–1979). N Engl J Med 301: 881–887, 1979.Google Scholar
  99. 99.
    Runyon BA, Labrecque DR, Anuras S: The spectrum of liver disease in systemic lupus erythematosus. Am J Med 69: 187–194, 1980.PubMedGoogle Scholar
  100. 100.
    Budman JR, Steinberg AD: Hematologic aspects of systemic lupus erythematosus. Ann Intern Med 86: 220–229, 1977.PubMedGoogle Scholar
  101. 101.
    Rivero SJ, Alger M, Alarcon-Segovia D: Splenectomy for hemocytopenia in systemic lupus erythematosus. Arch Intern Med 139: 773–776, 1979.PubMedGoogle Scholar
  102. 102.
    Peck B, Hoffman GS, Franck WA: Thrombophlebitis in systemic lupus erythematosus. JAMA 240: 1728–1730, 1978.Google Scholar
  103. 103.
    Cosgriff TM, Martin BA: Low functional and high antigenic antithrombin III level in a patient with lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 24: 94–96, 1981.PubMedGoogle Scholar
  104. 104.
    St. Clair W, Jones B, Rogers JS, et al.: Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 135: 230–232, 1981.Google Scholar
  105. 105.
    Pui C-H, Wilimas J, Wang W: Evans syndrome in childhood. J Pediatr 97: 754758, 1980.Google Scholar
  106. 106.
    Favre H, Chatelanat F, Miescher P: Autoimmune hematologic diseases associated with infraclinical systemic lupus erythematosus in four patients: A human equivalent of the NZB mice. Am J Med 66: 91–95, 1979.PubMedGoogle Scholar
  107. 107.
    White LE, Reeves JD: Polyarthritis and positive LE preparation in sickle hemoglobinopathies: A report of two cases. J Pediatr 95: 1003–1004, 1979.PubMedGoogle Scholar
  108. 108.
    Wallace DJ, Podell T, Weiner J, et al.: Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA 245: 934–938, 1981.Google Scholar
  109. 109.
    Cathcart ES, Scheinberg MA, Idelson BA: Beneficial effects of methylprednisone “pulse” therapy in diffuse proliferative lupus nephritis. Lancet 1: 163–166, 1976.PubMedGoogle Scholar
  110. 110.
    Cole BR, Brocklebank JT, Kienstra RA, et al.: “Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr 88: 307–314, 1976.PubMedGoogle Scholar
  111. 111.
    Garrett R, Paulus H: Complications of intravenous methylprednisone pulse therapy, abstracted. Arthritis Rheum 23: 677, 1980.Google Scholar
  112. 112.
    Moore WS, Guggenheim SJ, Anderson RJ: Diffuse proliferative lupus glomerulonephritis: Recovery from prolonged renal failure. JAMA 244: 63–65, 1980.Google Scholar
  113. 113.
    Amend W, Vincenti F, Covey C, et al.: Renal transplantation in systemic lupus erythematosus. Proc Eur Dial Transplant Assoc 7: 18–21, 1977.Google Scholar
  114. 114.
    Fries JF, Powers R, Kempson RL: Late-stage lupus nephropathy. J Rheum 1: 166175, 1974.Google Scholar
  115. 115.
    Laragh JH: Hypertension. Drug Therapy 10: 71–88, January 1980.Google Scholar
  116. 116.
    Dresner IG, Dysart NK, Michael AF, et al.: Central nervous system (CNS) lupus erythematosus (LE) in children, abstracted. Pediatr Res 12: 551, 1978.Google Scholar
  117. 117.
    Bishko F: Retinopathy in systemic lupus erythematosus. Arthritis Rheum 15: 5763, 1972.Google Scholar
  118. 118.
    Gold DH, Morris DA: Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 56: 800–804, 1972.PubMedGoogle Scholar
  119. 119.
    Silverman M, Lubeck MJ, Briney EG: Central retinal vein occlusion complicating systemic lupus erythematosus. Arthritis Rheum 21: 839–843, 1978.PubMedGoogle Scholar
  120. 120.
    Bennahum DA, Messner RP: Recent observations on CNS lupus erythematosus. Semin Arthritis Rheum 4: 253–266, 1975.PubMedGoogle Scholar
  121. 121.
    Feinglass EJ, Arnett FC, Dorsch CA, et al.: Neuropsychiatric manifestations of systemic lupus erythematosus: Diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 55: 323–339, 1976.PubMedGoogle Scholar
  122. 122.
    Yancey CL, Doughty RA, Athreya BH: Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum 24: 1389–1395, 1981.PubMedGoogle Scholar
  123. 123.
    Johnson RT, Richardson EP: The neurological manifestations of systemic lupus erythematosus. Medicine 47: 337–369, 1968.PubMedGoogle Scholar
  124. 124.
    Gershwin ME, Hyman LR, Steinberg AD: The choroid plexus in CNS involvement of systemic lupus erythematosus. J Pediatr 87: 588–590, 1975.PubMedGoogle Scholar
  125. 125.
    Bennahum DA, Messner RP, Shoop JD: Brain scan findings in central nervous system involvement by lupus erythematosus. Ann Intern Med 81: 763–765, 1974.PubMedGoogle Scholar
  126. 126.
    Pinching AJ, Travers RL, Hughes GRV: Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet 1: 888–890, 1978.Google Scholar
  127. 127.
    Bilaniuk LT, Patel S, Zimmerman RA: Computed tomography of systemic lupus erythematosus. Radiology 124: 119–121, 1977.PubMedGoogle Scholar
  128. 128.
    Brandt KD, Lessell S: Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum 21: 7–16, 1978.PubMedGoogle Scholar
  129. 129.
    Carlow TJ, Glaser JS: Pseudotumor cerebri in systemic lupus erythematosus. JAMA 228: 197–200, 1974.Google Scholar
  130. 130.
    Shoenfeld Y, Livni E, Shaklai M, et al.: Sensitization to ibuprofen in systemic lupus erythematosus. JAMA 244: 547–548, 1980.Google Scholar
  131. 131.
    Kassan SS, Lockshin MD: Central nervous system lupus erythematosus. Arthritis Rheum 22: 1382–1385, 1979.PubMedGoogle Scholar
  132. 132.
    Lehman TJA, Bernstein B, Hanson V, et al.: Meningococcal infection complicating systemic lupus erythematosus. J Pediatr 99: 94–96, 1981.PubMedGoogle Scholar
  133. 133.
    Brandt KD, Lessell S, Cohen AS: Cerebral disorders of vision in systemic lupus erythematosus. Ann Intern Med 83: 163–169, 1975.PubMedGoogle Scholar
  134. 134.
    Donaldson IM, Espiner EA: Disseminated lupus erythematosus presenting as chorea gravidarum. Arch Neurol 25: 240–244, 1971.PubMedGoogle Scholar
  135. 135.
    Lusins JO, Szilagyi PA: Clinical features of chorea associated with systemic lupus erythematosus. Am J Med 58: 857–861, 1975.PubMedGoogle Scholar
  136. 136.
    Groothius JR, Groothius DR, Mukhopadhyay D, et al.: Lupus-associated chorea in childhood. Am J Dis Child 131: 1131–1134, 1977.Google Scholar
  137. 137.
    Herd JK, Medhi M, Uzendoski DM, et al.: Chorea associated with systemic lupus erythematosus: Report of two cases and review of the literature. Pediatrics 61: 308315, 1978.Google Scholar
  138. 138.
    Andrianakos AA, Duffy J, Suzuki M, et al.: Transverse myelopathy in systemic lupus erythematosus: Report of three cases and review of the literature. Ann Intern Med 83: 616–624, 1975.PubMedGoogle Scholar
  139. 139.
    Wasner CK: Ibuprofen, meningitis, and systemic lupus erythematosus. J Rheum 5: 162–164, 1978.PubMedGoogle Scholar
  140. 140.
    Scheinberg L: Polyneuritis in systemic lupus erythematosus. Review of the literature and report of a case. N Engl J Med 255: 416–421, 1956.PubMedGoogle Scholar
  141. 141.
    Winfield JB, Brunner CM, Koffler D: Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 21: 289–294, 1978.PubMedGoogle Scholar
  142. 142.
    Strauer BE, Brune I, Schenk H, et al.: Lupus cardiomyopathy: Cardiac mechanics, hemodynamics, and coronary blood flow in uncomplicated systemic lupus erythematosus. Am Heart J 92: 715–722, 1976.PubMedGoogle Scholar
  143. 143.
    Bulkley BH, Roberts EC: The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 58: 243–264, 1975.PubMedGoogle Scholar
  144. 144.
    Greenberg JH, Lutcher CL: Drug-induced systemic lupus erythematosus: A case with life-threatening pericardial tamponade. JAMA 222: 191–193, 1972.Google Scholar
  145. 145.
    Carey RM, Coleman M, Feder A: Pericardial tamponade: A major presenting manifestation of hydralazine-induced lupus syndrome. Am J Med 54: 84–87, 1973.PubMedGoogle Scholar
  146. 146.
    Jacobson EJ, Reza JJ: Constrictive pericarditis in systemic lupus erythematosus; demonstration of immunoglobulins in the pericardium. Arthritis Rheum 21: 97 2974, 1978.Google Scholar
  147. 147.
    Borenstein DG, Fye WB, Arnett FC, et al.: The myocarditis of systemic lupus erythematosus: Association with myositis. Ann Intern Med 89: 619–624, 1978.PubMedGoogle Scholar
  148. 148.
    Ishikawa S, Segar WE, Gilbert EF: Myocardial infarction in a child with systemic lupus erythematosus. Am J Dis Child 132: 696–698, 1978.PubMedGoogle Scholar
  149. 149.
    Bonfiglio TA, Botti RE, Hagstrom JWC: Coronary arteritis, occlusion and myocardial infarction due to systemic lupus erythematosus. Am Heart J 83: 153–158, 1972.PubMedGoogle Scholar
  150. 150.
    Etheridge EM, Hoch-Legeti C: Lipid deposition in aortas in younger age groups following cortisone and adrenocorticotropic hormone. Am J Pathol 28: 315–332, 1952.PubMedGoogle Scholar
  151. 151.
    Gross M, Esterly JR, Earle RH: Pulmonary alterations in systemic lupus erythematosus. Am Rev Resp Dis 105: 572–577, 1972.PubMedGoogle Scholar
  152. 152.
    Matthay RA, Schwartz MI, Petty TL, et al.: Pulmonary manifestations of systemic lupus erythematosus: Review of twelve cases of acute lupus pneumonitis. Medicine 54: 397–409, 1974.Google Scholar
  153. 153.
    Inoue T, Kanayama Y, Ohe A, et al.: Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann Intern Med 91: 30–34, 1979.PubMedGoogle Scholar
  154. 154.
    Fayemi AO: Pulmonary vascular disease in systemic lupus erythematosus. Am J Clin Pathol 65: 284–290, 1976.PubMedGoogle Scholar
  155. 155.
    Moser KM: Diagnosis and management of pulmonary embolism. Hosp Pract 15 (10): 57–68, October 1980.PubMedGoogle Scholar
  156. 156.
    Sharma GVRK, Burleson VA, Sasahara AA: Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. N Engl J Med 303: 842–845, 1980.PubMedGoogle Scholar
  157. 157.
    Hull R, Hirsh J, Sackett DL, et al.: Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis. N Engl J Med 304: 1561–1567, 1981.PubMedGoogle Scholar
  158. 158.
    Rajani KB, Ashbacher LV, Kinney TR: Pulmonary hemorrhage and systemic lupus erythematosus. J Pediatr 93: 810–812, 1978.PubMedGoogle Scholar
  159. 159.
    Bernstein B, Koster-King K, Singsen B, et al.: Sjögren’s syndrome in childhood. Arthritis Rheum 20: 361–362, 1977.Google Scholar
  160. 160.
    Athreya B, Norman ME, Myers AR, et al.: Sjögren’s syndrome in children. Pediatrics 59: 931–938, 1977.PubMedGoogle Scholar
  161. 161.
    Jackson J, Anderson L, Schur P, et al.: Sjögren’s syndrome in juvenile rheumatoid arthritis (JRA), abstracted. Arthritis Rheum 16: 122, 1973.Google Scholar
  162. 162.
    Strand V, Talal N: Advances in the diagnoses and concept of Sjögren’s syndrome (autoimmune exocrinopathy). Bull Rheum Dis 30: 1046–1052, 1980.Google Scholar
  163. 163.
    Kassan SS, Thomas TL, Moutsopoulos HM, et al.: Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89: 888–892, 1978.PubMedGoogle Scholar
  164. 164.
    Fraga A, Gudino J, Ramos-Niembro F, et al.: Mixed connective tissue disease in childhood: Relationship with Sjögren’s syndrome. Am J Dis Child 132: 263–266, 1978.PubMedGoogle Scholar
  165. 165.
    Singsen BH, Swanson VL, Bernstein BH, et al.: A histologic evaluation of mixed connective tissue disease in childhood. Am J Med 68: 710–717, 1980.PubMedGoogle Scholar
  166. 166.
    Klipper AR, Stevens MB, Zizic TM, et al.: Ischemic necrosis of bone in systemic lupus erythematosus. Medicine 55: 251–257, 1976.PubMedGoogle Scholar
  167. 167.
    Bergstein JM, Wiens C, Fish AJ, et al.: Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr 85: 31–35, 1974.PubMedGoogle Scholar
  168. 168.
    Abeles M, Urman JD, Rothfield NF: Aseptic necrosis of bone in systemic lupus erythematosus: Relationship to corticosteroid therapy. Arch Intern Med 138: 750754, 1978.Google Scholar
  169. 169.
    Grossman J, Koval NS, Condemi JJ: Systemic lupus erythematosus: Bilateral aseptic necrosis of hip. NY State J Med 75: 1523–1526, 1975.Google Scholar
  170. 170.
    Zizic TM, Hungerford DS, Stevens MB: Ischemic bone necrosis in systemic lupus erythematosus. Medicine 59: 134–148, 1980.PubMedGoogle Scholar
  171. 171.
    Garsenstein M, Pollak VE, Kark RM: Systemic lupus erythematosus and pregnancy. N Engl J Med 267: 165–169, 1962.PubMedGoogle Scholar
  172. 172.
    Estes D, Larson DL: Systemic lupus erythematosus and pregnancy. Clin Obstet Gynecol 8: 307–321, 1965.Google Scholar
  173. 173.
    McGee CD, Makowski EL: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 107: 1008–1012, 1970.PubMedGoogle Scholar
  174. 174.
    Bear R: Pregnancy and lupus nephritis. Obstet Gynecol 47: 715–718, 1975.Google Scholar
  175. 175.
    Editorial: Pregnancy and renal disease. Lancet 2: 801–802, 1975.Google Scholar
  176. 176.
    Vonderheid EC, Koblenzer PJ, Ming PML, et al.: Neonatal lupus erythematosus. Arch Dermatol 112: 698–705, 1976.PubMedGoogle Scholar
  177. 177.
    Crittenen IH: Rheumatoid arthritis in the mother of five siblings with congenital heart block. N Engl J Med 299: 491–492, 1978.PubMedGoogle Scholar
  178. 178.
    Chameides L, Truex RC, Vetter V, et al.: Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 297: 1204 1208, 1977.Google Scholar
  179. 179.
    Nolan RJ, Shulman ST, Victorica BE: Congenital complete heart block associated with maternal mixed connective tissue disease. J Pediatr 95: 420–422, 1979.PubMedGoogle Scholar
  180. 180.
    Hardy JD, Banwell GS, Beach R, et al.: Congenital complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders. Arch Dis Child 54: 7–13, 1979.PubMedGoogle Scholar
  181. 181.
    Editorial: Systemic lupus in the newborn. Lancet 1: 859, 1979.Google Scholar
  182. 182.
    Doshi N, Smith B, Klionsky B: Congenital pericarditis due to maternal lupus erythematosus. J Pediatr 96: 699–701, 1980.PubMedGoogle Scholar
  183. 183.
    Klippel JH, Grimley PM, Decker JL: Lymphocyte inclusions in newborns of mothers with systemic lupus erythematosus. N Engl J Med 290: 97–98, 1974.Google Scholar
  184. 184.
    Levy SB, Goldsmith LA, Morohashi M, et al.: Tubuloreticular inclusions in neonatal lupus erythematosus. JAMA 235: 2743–2744, 1976.Google Scholar
  185. 185.
    Ty A, Fine BP: Infantile systemic lupus erythematosus (SLE) associated with chromosomal abnormalities presenting as nephrotic syndrome, abstracted. Pediatr Res 12: 548, 1978.Google Scholar
  186. 186.
    Beernick DH, Miller JJ: Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children. J Pediatr 82: 113–117, 1973.Google Scholar
  187. 187.
    Singsen BH, Fishman L, Hanson V: Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants. Pediatrics 57: 529–534, 1976.PubMedGoogle Scholar
  188. 188.
    Lee SL, Chase PH: Drug-induced systemic lupus erythematosus: A critical review. Semin Arthritis Rheum 5: 83–103, 1975.PubMedGoogle Scholar
  189. 189.
    Irias JJ: Hydralazine-induced lupus erythematosus-like syndrome. Am J Dis Child 129: 862–864, 1975.PubMedGoogle Scholar
  190. 190.
    Woosley RL, Drayer DE, Reidenberg MM, et al.: Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 298: 1157–1159, 1978.PubMedGoogle Scholar
  191. 191.
    Batchelor JR, Welsh KI, Tinoco RM, et al.: Hydralazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility. Lancet 1: 1107 1109, 1980.Google Scholar
  192. 192.
    Hess EV (ed.): Proceedings of the Kroc foundation conference on drug-induced lupus. Arthritis Rheum 24:979–1112, 1981.Google Scholar
  193. 193.
    Massimo L, Pasino M, Rosando-Vadala C, et al.: Immunological side-effects of anticonvulsants. Lancet 1: 860, 1976.PubMedGoogle Scholar
  194. 194.
    Kirtland HH, Mohler DN, Horwitz DA: Methyldopa inhibition of suppressor-lymphocyte function. N Engl J Med 302: 825–832, 1980.PubMedGoogle Scholar
  195. 195.
    Grossman L, Barland P: Histone reactivity of drug-induced antinuclear antibodies: A comparison of symptomatic and asymptomatic patients. Arthritis Rheum 24: 927931, 1981.Google Scholar
  196. 196.
    Miller JJ III: Drug-induced lupus-like syndromes in children. Arthritis Rheum 20: 308–311, 1977.PubMedGoogle Scholar
  197. 197.
    Weinstein J: Hypocomplementemia in hydralazine-associated systemic lupus erythematosus. Am J Med 65: 553–556, 1978.PubMedGoogle Scholar
  198. 198.
    Sharp GC, Irvin WS, Tan EM, et al.: Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA). Am J Med 52: 148–159, 1972.PubMedGoogle Scholar
  199. 199.
    Sharp GC: Mixed connective tissue disease. Bull Rheum Dis 25: 828–830, 1975.Google Scholar
  200. 200.
    Sharp GC, Irvin WS, May CM, et al.: Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 296: 1149–1154, 1976.Google Scholar
  201. 201.
    Hamburger M, Hodes S, Barland P: The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci 273: 21–28, 1977.PubMedGoogle Scholar
  202. 202.
    Singsen BH, Bernstein BH, Kornreich HK, et al.: Mixed connective tissue disease in childhood: A clinical and serologic survey. J Pediatr 90: 893–900, 1977.PubMedGoogle Scholar
  203. 203.
    Baldassare A, Weiss T, Auclair R, et al.: Mixed connective tissue disease (MCTD) in children, abstracted. Arthritis Rheum 19: 788, 1976.Google Scholar
  204. 204.
    Hutto JH, Ayoub EM: Mixed connective tissue disease in children, abstracted. Pediatr Res 11: 488, 1977.Google Scholar
  205. 205.
    Oetgen WJ, Boice JA, Lawless OJ: Mixed connective tissue disease in children and adolescents. Pediatrics 67: 333–337, 1981.PubMedGoogle Scholar
  206. 206.
    Nimelstein SH, Brody S, McShane D, et al.: Mixed connective tissue disease: A subsequent evaluation of the original 25 patients. Medicine 59: 239–248, 1980.PubMedGoogle Scholar
  207. 207.
    Ehrlich GE: Systemic lupus erythematosus. JAMA 232: 1361–1363, 1975.Google Scholar
  208. 208.
    Jacobs JC: Treatment of systemic lupus erythematosus in childhood. Arthritis Rheum 20: 304–307, 1977.PubMedGoogle Scholar
  209. 209.
    Wasner CK, Fries JF: Treatment decisions in systemic lupus erythematosus. Arthritis Rheum 23: 283–286, 1980.PubMedGoogle Scholar
  210. 210.
    Gladman DD, Urowitz MD, Keystone EC: Serologically active clinically quiescent systemic lupus erythematosus: A discordance between clinical and serologic features. Am J Med 111: 210–216, 1979.Google Scholar
  211. 211.
    Donadio JV Jr, Holley KE, Ferguson RH, et al.: Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299: 1151–1155, 1978.PubMedGoogle Scholar
  212. 212.
    Ibid: Letter to the Editor. N Engl J Med 300: 564–565, 1979.Google Scholar
  213. 213.
    Schur PH, Sandson J: Immunological factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278: 533–538, 1968.PubMedGoogle Scholar
  214. 214.
    Bardana EJ, Harbeck RJ, Hoffman AA, et al.: The prognostic and therapeutic implications of DNA: anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am J Med 59: 515–522, 1975.PubMedGoogle Scholar
  215. 215.
    Hecht B, Siegel N, Adler M, et al.: Prognostic indices in lupus nephritis. Medicine 55: 163–181, 1976.PubMedGoogle Scholar
  216. 216.
    Urman JD, Rothfield NF: Corticosteroid treatment in systemic lupus erythematosus: Survival studies. JAMA 238: 2270–2276, 1977.Google Scholar
  217. 217.
    Swaak AJG, Aarden LA, Van Eps LWS, et al.: Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22: 226235, 1979.Google Scholar
  218. 218.
    Jarrett MP, Walter L, Barland P, et al.: The effect of continuous normalization of serum complement (CHSO) on the course of lupus nephritis. A five year prospective study, abstracted. Arthritis Rheum 23: 697, 1980.Google Scholar
  219. 219.
    Garin EH, Donnelly WH, Shulman ST, et al.: The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis. Clin Nephrol 12: 148–155, 1979.PubMedGoogle Scholar
  220. 220.
    Pollak VE, Pirani CL, Kark RM: Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis. J Lab Clin Med 57: 495–511, 1961.PubMedGoogle Scholar
  221. 221.
    Rothfield NF, McCluskey R, Baldwin DS: Renal disease in systemic lupus erythematosus. N Engl J Med 269: 537–544, 1963.PubMedGoogle Scholar
  222. 222.
    Hagge WW, Burke EC, Stickler GB: Treatment of systemic lupus erythematosus complicated by nephritis in children. Pediatrics 40: 822–827, 1967.PubMedGoogle Scholar
  223. 223.
    Ackerman GL: Alternate-day steroid therapy in lupus nephritis. Ann Intern Med 72: 511–519, 1970.PubMedGoogle Scholar
  224. 224.
    Donadio JV Jr, Holley KE, Wagoner RD, et al.: Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann Intern Med 77: 829835, 1972.Google Scholar
  225. 225.
    Sztejnbok M, Stewart A, Diamond H, et al.: Azathioprine in the treatment of systemic lupus erythematosus: A controlled study. Arthritis Rheum 14: 639–645, 1971.PubMedGoogle Scholar
  226. 226.
    Ginzler E, Sharon E, Diamond H, et al.: Long-term maintenance therapy with azathioprine in systemic lupus erythematosus. Arthritis Rheum 18: 27–35, 1975.PubMedGoogle Scholar
  227. 227.
    Barnett EV, Dornfeld L, Lee DB, et al.: Long-term survival of lupus nephritis patients treated with azathioprine and prednisone. J Rheum 5: 275–287, 1978.PubMedGoogle Scholar
  228. 228.
    Drinkard JP, Stanley TM, Dornfeld L, et al.: Azathioprine and prednisone in the treatment of adults with lupus nephritis. Medicine 49: 411–432, 1970.PubMedGoogle Scholar
  229. 229.
    Shelp WD, Bloodworth JMB Jr, Riselbach RE: Effect of azathioprine on renal histology and function in lupus nephritis. Arch Intern Med 128: 566–573, 1971.PubMedGoogle Scholar
  230. 230.
    Hayslett JP, Kashgarian M, Cook CD, et al.: The effect of azathioprine on lupus glomerulonephritis. Medicine 51: 393–412, 1972.PubMedGoogle Scholar
  231. 231.
    Hahn B, Kantor O, Osterland K: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Ann Intern Med 83: 592–605, 1975.Google Scholar
  232. 232.
    Donadio JV, Holley KE, Wagoner RD, et al.: Further observations in the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum 17: 573–581, 1974.PubMedGoogle Scholar
  233. 233.
    Steinberg AD, Plotz PH, Wolf SM, et al.: Cytotoxic drugs in treatment of nonmalignant diseases. Ann Intern Med 76: 619–642, 1972.Google Scholar
  234. 234.
    Schneck SA, Penn I: De-novo brain tumors in renal transplant recipients. Lancet 1: 983–986, 1971.PubMedGoogle Scholar
  235. 235.
    Tallent MB, Simmons RL, Najarian JS: Birth defects in child of male recipient of kidney transplant. JAMA 211: 1854–1855, 1970.Google Scholar
  236. 236.
    Malkzedah MH, Grushkin CM, Wright HT Jr. et al.: Hepatic dysfunction after renal transplantation in children. J Pediatr 81: 279–285, 1972.Google Scholar
  237. 237.
    Reed WP, Lucas ZJ, Cohn R: Alternate-day prednisone therapy after renal transplantation. Lancet 1: 747–749, 1970.PubMedGoogle Scholar
  238. 238.
    Walron J, Watson BS, Ney RL: Alternate-day vs. shorter-interval steroid administration. Arch Intern Med 126: 601–607, 1970.Google Scholar
  239. 239.
    Jacobson ME: The rationale of alternate-day corticosteroid therapy. Postgrad Med 49: 181–187, 1971.PubMedGoogle Scholar
  240. 240.
    McAdams AJ, McEnery PT, West CD: Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapy. J Pediatr 86: 23–31, 1975.PubMedGoogle Scholar
  241. 241.
    Bolton WK, Atuk NO, Sturgill BC, et al.: Therapy of the idiopathic nephrotic syndrome with alternate-day steroids. Am J Med 62: 60–70, 1977.PubMedGoogle Scholar
  242. 242.
    Fauci AS: Alternate-day corticosteroid therapy. Am J Med 64: 729–731, 1978.PubMedGoogle Scholar
  243. 243.
    Coggins CH (ed.): A controlled study of short-term prednisone treatment in adults with membranous nephropathy: Collaborative study of the adult idiopathic nephrotic syndrome. N Engl J Med 301:1301–1306, 1979.Google Scholar
  244. 244.
    Breitenfeld RV, Hebert LA, Lemann J, et al.: Stability of renal transplant function with alternate-day corticosteroid therapy. JAMA 244: 151–156, 1980.Google Scholar
  245. 245.
    Macgregor RR, Sheagren JN, Lipsett MB, et al.: Alternate-day prednisone therapy: Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med 280: 1427–1431, 1969.PubMedGoogle Scholar
  246. 246.
    McEnery PT, Gonzalez LL, Martin LW, et al.: Growth and development of children with renal transplants. Use of alternate-day steroid therapy. J Pediatr 83: 806814, 1973.Google Scholar
  247. 247.
    Dale DC, Fauci AS, Wolff SM: Alternate-day prednisone: Leucocyte kinetics and susceptibility to infections. N Engl J Med 291: 1154–1158, 1974.PubMedGoogle Scholar
  248. 248.
    Shaprio GG, Tuttoni DS, Kelley VC, et al.: Growth, pulmonary, and endocrine function in chronic asthma patients on daily and alternate day adrenocorticoid therapy. J Allergy Clin Immunol 57: 430–439, 1976.Google Scholar
  249. 249.
    Seaman WE, Ishak KG, Plotz PH: Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med 80: 1–8, 1974.PubMedGoogle Scholar
  250. 250.
    Ruppert GB, Barth WF: Tolmetin-induced aseptic meningitis. JAMA 245: 67–68, 1981.Google Scholar
  251. 251.
    Gordon MF, Stolley PD, Schinnar R: Trends in recent systemic lupus erythematosus mortality rates. Arthritis Rheum 24: 762–765, 1981.PubMedGoogle Scholar
  252. 252.
    Steinberg AD, Kaltreider HB, Staples PJ, et al.: Cyclophosphamide in lupus nephritis: A controlled trial. Ann Intern Med 75: 165–171, 1971.PubMedGoogle Scholar
  253. 253.
    Donadio JV Jr, Holley KE, Ferguson RH, et al.: Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide. Mayo Clin Proc 51: 484–494, 1976.PubMedGoogle Scholar
  254. 254.
    Donadio JV Jr, Holley KE, Ferguson RH, et al.: Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299: 1151–1155, 1978.PubMedGoogle Scholar
  255. 255.
    Dinant HJ, Klippel JH, Decker JL, et al.: Randomized trial of cyclophosphamide plus azathioprine and intravenous cyclophosphamide in lupus nephritis, abstracted. Arthritis Rheum 23: 666, 1980.Google Scholar
  256. 256.
    Aptekar RG, Atkinson JP, Decker JL, et al.: Bladder toxicity with chronic oral cyclophosphamide therapy in non-malignant disease. Arthritis Rheum 16: 461–467, 1973.PubMedGoogle Scholar
  257. 257.
    Warne GL, Fairley KF, Hobbs JB, et al.: Cyclophosphamide-induced ovarian failure. N Engl J Med 289: 1159–1162, 1973.PubMedGoogle Scholar
  258. 258.
    Tannenbaum H, Schur PH: Development of reticulum cell sarcoma during cyclophosphamide therapy. Arthritis Rheum 17: 15–18, 1974.PubMedGoogle Scholar
  259. 259.
    Pollock BH, Barr JH Jr, Stolzer BL, et al.: Neoplasia and cyclophosphamide. Arthritis Rheum 16: 524–526, 1973.Google Scholar
  260. 260.
    Walker SE, Anver MR: Accelerated appearance of neoplasms in female NZB/ NZW mice treated with high-dose cyclophosphamide. Arthritis Rheum 22: 1338 1343, 1979.Google Scholar
  261. 261.
    Verrier Jones J, Fraser ID, Bothamley J, et al.: A therapeutic role for plasmapheresis in the management of acute systemic lupus erythematosus. Plasma Ther 1: 33–41, 1979.Google Scholar
  262. 262.
    Lockwood CM, Worlledge S, Nicholas A, et al.: Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 300: 524–530, 1979.PubMedGoogle Scholar
  263. 263.
    Terman DS, Buffaloe G, Mattioli C, et al.: Extracorporeal immunoadsorption: Initial experience in human systemic lupus erythematosus. Lancet 2: 824–827, 1979.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Jerry C. Jacobs
    • 1
  1. 1.Section of Pediatric Rheumatology Department of Pediatrics College of Physicians and SurgeonsColumbia UniversityNew YorkUSA

Personalised recommendations